no abstract available
Design of an ongoing phase I/II open-label, dose-escalation trial using the oral chelator deferasirox to treat iron overload in HFE-Related hereditary hemochromatosis (HH) / Pietrangelo, A., Brissot, P., Bonkovsky, H., Niederau, C., Rojkjaer, L., Weitzman, R., Bodner, J., Bailey, S., Phatak, P.d.. - In: BLOOD. - ISSN 0006-4971. - 110:11(2007), pp. 788A-788A. (49th Annual Meeting of the American-Society-of-Hematology Atlanta, GA DEC 08-11, 2007).
Design of an ongoing phase I/II open-label, dose-escalation trial using the oral chelator deferasirox to treat iron overload in HFE-Related hereditary hemochromatosis (HH)
PIETRANGELO, Antonello;
2007
Abstract
no abstract availablePubblicazioni consigliate

I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris




